Market Overview:
The global non-invasive biosensors market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for portable and easy-to-use devices, rising prevalence of chronic diseases, and growing awareness about early diagnosis and treatment. Based on type, the breathalyzers segment is expected to account for the largest share of the global non-invasive biosensors market in 2018. This segment is projected to grow at a CAGR of 11.5% during the forecast period. The large share of this segment can be attributed to factors such as increasing incidence of alcohol abuse and rising demand for portable breath analyzers worldwide. Based on application, hospitals are expected to account for the largest share of the global non-invasive biosensors market in 2018. This segment is projected grow at a CAGRof 10%.
Product Definition:
Non- invasive biosensors are devices that can detect the presence of a target molecule without penetrating the skin or body. These devices are often used for medical diagnostics, environmental monitoring, and food safety testing. Non- invasive biosensors have several advantages over traditional methods such as blood tests and biopsies. They are less invasive, faster, and more accurate. Additionally, they can be used to monitor tissue function in real time, which is important for diagnosing conditions like heart attack or stroke.
Breathalyzers:
Breathalyzers are devices that measure the amount of alcohol in a person's breath. They are used by law enforcement agencies to detect whether a driver is under the influence of alcohol. The growth factor in non-invasive biosensors market is that they provide an alternative for breathalyzer tests as they do not involve direct contact with subject and hence reduce the chances of cross contamination, which makes them more reliable than traditional methods.
Glucose monitors:
Glucose monitors are biosensors that are used for measuring the glucose level in the body. The major applications of these sensors include diabetes management and diagnosis of hypoglycemia (low blood sugar). These devices have a wide range of applications such as newborn screening, fertility testing, pregnancy testing, and disease diagnostics.
Application Insights:
The hospital segment dominated the global non- invasive biosensors market in 2017 and is expected to maintain its dominance over the forecast period. The growing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, cancer and respiratory disorders coupled with rising geriatric population across the globe is anticipated to drive demand for NIIB devices in hospitals.
Non-invasive blood glucose monitoring systems have revolutionized diabetes management by enabling patients with little or no insulin production capability to manage their blood glucose levels effectively. These devices help patients comply with medical recommendations by providing real-time data on a user¢â‚¬â„¢s blood glucose level through a small sensor that is inserted under the skin. This has led to an increase in their adoption rate among people suffering from diabetes mellitus around the world.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of non-invasive techniques, and favorable reimbursement policies & regulatory approvals. The U.S is one of the most lucrative markets for these devices as it has a well-established healthcare infrastructure and growing geriatric population base that requires constant monitoring & attention.
Asia Pacific is expected to witness rapid growth over the forecast period owing to factors such as improving healthcare facilities due to increasing government spending on health care, rising awareness about early diagnosis among patients suffering from chronic diseases like diabetes & hypertension, and an increase in disposable income levels resulting into higher demand for medical products/services amongst end users (patients). Moreover, rapidly developing economies coupled with supportive economic policies by governments are anticipated to boost industry growth across this region during the forecast period (2018 - 2030).
Growth Factors:
- Increasing demand for minimally invasive and non-invasive diagnostic procedures
- Rising prevalence of chronic diseases that require continuous monitoring
- Growing demand for point-of-care diagnostics
- Technological advancements in biosensors technology
- Increasing funding for research and development in biosensors
Scope Of The Report
Report Attributes
Report Details
Report Title
Non- Invasive Biosensors Market Research Report
By Type
Breathalyzers, Glucose monitors, Blood Analyses Monitors, Others
By Application
Hospitals, Homecare Settings, Others
By Companies
Akers Biosciences, Inc, Philips Healthcare, Abbott Laboratories, GE Healthcare, Nemaura Medical, Inc, Integrity Applications Inc, OrSense, MediWise Ltd, Medtronic Plc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Non- Invasive Biosensors Market Report Segments:
The global Non- Invasive Biosensors market is segmented on the basis of:
Types
Breathalyzers, Glucose monitors, Blood Analyses Monitors, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Homecare Settings, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Akers Biosciences, Inc
- Philips Healthcare
- Abbott Laboratories
- GE Healthcare
- Nemaura Medical, Inc
- Integrity Applications Inc
- OrSense
- MediWise Ltd
- Medtronic Plc
Highlights of The Non- Invasive Biosensors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Breathalyzers
- Glucose monitors
- Blood Analyses Monitors
- Others
- By Application:
- Hospitals
- Homecare Settings
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non- Invasive Biosensors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-invasive biosensors are sensors that do not require any invasive procedures, such as surgery or puncture. They can be placed on the body surface or inside the body.
Some of the major players in the non- invasive biosensors market are Akers Biosciences, Inc, Philips Healthcare, Abbott Laboratories, GE Healthcare, Nemaura Medical, Inc, Integrity Applications Inc, OrSense, MediWise Ltd, Medtronic Plc.
The non- invasive biosensors market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non- Invasive Biosensors Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non- Invasive Biosensors Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non- Invasive Biosensors Market - Supply Chain
4.5. Global Non- Invasive Biosensors Market Forecast
4.5.1. Non- Invasive Biosensors Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non- Invasive Biosensors Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non- Invasive Biosensors Market Absolute $ Opportunity
5. Global Non- Invasive Biosensors Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non- Invasive Biosensors Market Size and Volume Forecast by Type
5.3.1. Breathalyzers
5.3.2. Glucose monitors
5.3.3. Blood Analyses Monitors
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non- Invasive Biosensors Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non- Invasive Biosensors Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Homecare Settings
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non- Invasive Biosensors Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non- Invasive Biosensors Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non- Invasive Biosensors Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non- Invasive Biosensors Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non- Invasive Biosensors Demand Share Forecast, 2019-2026
9. North America Non- Invasive Biosensors Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non- Invasive Biosensors Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non- Invasive Biosensors Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Homecare Settings
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non- Invasive Biosensors Market Size and Volume Forecast by Type
9.7.1. Breathalyzers
9.7.2. Glucose monitors
9.7.3. Blood Analyses Monitors
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non- Invasive Biosensors Demand Share Forecast, 2019-2026
10. Latin America Non- Invasive Biosensors Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non- Invasive Biosensors Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non- Invasive Biosensors Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Homecare Settings
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non- Invasive Biosensors Market Size and Volume Forecast by Type
10.7.1. Breathalyzers
10.7.2. Glucose monitors
10.7.3. Blood Analyses Monitors
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non- Invasive Biosensors Demand Share Forecast, 2019-2026
11. Europe Non- Invasive Biosensors Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non- Invasive Biosensors Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non- Invasive Biosensors Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Homecare Settings
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non- Invasive Biosensors Market Size and Volume Forecast by Type
11.7.1. Breathalyzers
11.7.2. Glucose monitors
11.7.3. Blood Analyses Monitors
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non- Invasive Biosensors Demand Share, 2019-2026
12. Asia Pacific Non- Invasive Biosensors Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non- Invasive Biosensors Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non- Invasive Biosensors Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Homecare Settings
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non- Invasive Biosensors Market Size and Volume Forecast by Type
12.7.1. Breathalyzers
12.7.2. Glucose monitors
12.7.3. Blood Analyses Monitors
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non- Invasive Biosensors Demand Share, 2019-2026
13. Middle East & Africa Non- Invasive Biosensors Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non- Invasive Biosensors Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non- Invasive Biosensors Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Homecare Settings
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non- Invasive Biosensors Market Size and Volume Forecast by Type
13.7.1. Breathalyzers
13.7.2. Glucose monitors
13.7.3. Blood Analyses Monitors
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non- Invasive Biosensors Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Non- Invasive Biosensors Market: Market Share Analysis
14.2. Non- Invasive Biosensors Distributors and Customers
14.3. Non- Invasive Biosensors Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Akers Biosciences, Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Philips Healthcare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott Laboratories
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GE Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nemaura Medical, Inc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Integrity Applications Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. OrSense
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. MediWise Ltd
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Medtronic Plc
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
